Enzo Biochem Stock (NYSE: ENZ) stock price, news, charts, stock research, profile.
Open | $1.110 |
Close | - |
Volume / Avg. | 63.517K / 104.751K |
Day Range | 1.090 - 1.139 |
52 Wk Range | 0.990 - 2.500 |
Market Cap | $58.397M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NYSE |
RSI | 52 |
Short Interest | 1.75% |
Days to Cover | 6.08 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Enzo Biochem (NYSE: ENZ) through any online brokerage.
Other companies in Enzo Biochem’s space includes: Prenetics Global (NASDAQ:PRE), ATI Physical Therapy (NYSE:ATIP), Star Equity Hldgs (NASDAQ:STRR), Novo Integrated Sciences (NASDAQ:NVOS) and Mobile-health Network (NASDAQ:MNDR).
The latest price target for Enzo Biochem (NYSE: ENZ) was reported by Craig-Hallum on Tuesday, February 4, 2014. The analyst firm set a price target for 5.50 expecting ENZ to rise to within 12 months (a possible 391.07% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Enzo Biochem (NYSE: ENZ) is $1.12 last updated Today at May 16, 2024 at 12:37 PM EDT.
There are no upcoming dividends for Enzo Biochem.
Enzo Biochem’s Q3 earnings are confirmed for Wednesday, June 12, 2024.
There is no upcoming split for Enzo Biochem.
Enzo Biochem is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.